BeStock  
Markets › Compare › IMTX vs MLTX

IMTX vs MLTX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
IMTX · Immatics$5.77 ▼ 3.03%
MLTX · MoonLake Immunotherapeutics$11.07 ▲ 0.36%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

4880111143175Nov 24, '25May 26, '26Nov 20, '26
  • IMTX -45.6%
  • MLTX -15.8%

Head to head

MetricIMTXMLTX
Price$5.77$11.07
Change today▼ 3.03%▲ 0.36%
Market cap$878.58M$942.13M
Return, 3 months-33.6%-28.0%
Return, year to date-45.0%-16.0%
Return, 1 year-43.4%-12.6%
P/E (TTM)––
P/B1.82.5
P/E percentile vs own 5y77th87th
Dividend yield––
Revenue growth (YoY, latest qtr)+33.5%–
Net profit growth (YoY)-50.4%-12.5%
Gross margin––
Operating margin-577.1%–
Net margin-526.6%–
Return on equity-53.5%-81.6%
Analyst target vs. price+173.1%+221.3%
Analyst buy share100%88%
RSI (14)2944
30-day volatility56.4%80.9%
Max drawdown, 1 year-51.4%-56.9%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • MLTX is the largest of the group by market value.
  • MLTX has returned the most over the past year.
  • IMTX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top